Navigation Links
Ophthalmologists Invited To Participate in Betadine for EKC Treatment Study

LITTLE SILVER, N.J., July 2 /PRNewswire/ -- Dr Daniel Goldberg, a leading New Jersey ophthalmologist is coordinating a new study to measure the effectiveness of using 5% Betadine irrigation for treatment of acute EKC -- a common, worldwide, highly contagious and often severe form of conjunctivitis with the potential for long term visual impairment due to corneal involvement.

Ophthalmologists around the world are invited to register to participate in the Betadine for EKC study. The purpose of the new study is to confirm the effectiveness of this protocol and to expand the awareness amongst eye care professionals of this inexpensive treatment for EKC.

The study is being coordinated by Dr Daniel Goldberg, Clinical Associate Professor of Ophthalmology, Drexel College of Medicine as well as committee and staff members of Atlantic Eye Physicians, in Long Branch, Little Silver, and Holmdel New Jersey. This protocol is open to ophthalmologists, US and international, who agree to follow the protocol and report clinical results thru the Betadine for EKC website ( ). The initial phase will be collecting data thru October 1, 2009, and it is anticipated that subsequently there will be modifications to the protocol and study design.

For more information about the new study, please visit

Information on registration is available at

About Dr Goldberg

Dr. Daniel Goldberg specializes in comprehensive refractive surgery including LASIK eye surgery and refractive intraocular lens and cataract surgery. He is a founding member of Atlantic Eye Physicians, an ophthalmology-led comprehensive eye care practice with offices at Long Branch, Little Silver, and Holmdel New Jersey. Drs Michael Su and Lisa Ortenzio at Atlantic Eye Physicians are collaborating with Dr. Goldberg on the Betadine for EKC Study.

SOURCE Pasch Consulting Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Glaucoma Survey: Half Unaware of Preservative-Free Beta-Blocker, Ophthalmologists Cite Benefits of Preservative-Free Medications on Ocular Comfort and Quality of Life
2. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
3. Cincinnati Adoption Agency Invited to Participate in Values Voter Presidential Debate
4. Families Invited to Celebrate Shire Day at Boston Childrens Museum
5. AUDIO from Medialink and Philips: Getting Rid of the Uninvited Holiday Guests on Your Toothbrush
6. Budding Young Artists Invited to Compete in 17th Annual Pier 1 Imports/UNICEF Greeting Card Contest
7. CyberKnife Centers of Miami, Palm Beach and Tampa Invited to Join M.D. Anderson Cancer Center Study
8. Kentucky-Based Sports Medicine Duo Invited to Astros Spring Training Camp
9. Media Invited to Attend International Society for Heart & Lung Transplantation Meeting in Boston, April 9-12
10. Pharsight Invited to Present on Antiviral Modeling and Simulation at DIA Adherence Workshop
11. Pharsight Invited to Present on Modeling and Simulation at ARCS Australia Scientific Congress
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... the way that they are handling security in light of the recent terrorist attacks ... in an attempt to stop an attack from reaching U.S. soil. Especially around special ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss ... to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When ... said an inventor from Hillside, N.J. "Many people catch diseases simply from sitting ... individuals will always be protected from germs." , He developed the patent-pending QUDRATECS ...
(Date:11/27/2015)... ... ... The print component of “Supporting Our Caregivers” is distributed ... Minneapolis, South Florida, with a circulation of approximately 250,000 copies and an estimated ... media strategy and across a network of top news sites and partner media ...
(Date:11/27/2015)... ... ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of its ... 3.7 billion people under the age of 50 – or 67% of the population - ... estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ) today announced that ... York State Attorney General,s Office to end the ... statutes with the Attorney General over the decision of Forest ... selling the now generic version of memantine immediate release tablets.  ... released its counterclaims against New York , ...
Breaking Medicine Technology: